Ken Griffin Lensar, Inc. Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$3.99 - $5.44 $38,703 - $52,768	-9,700 Reduced 40.93%	14,000 $64,000
Q2 2024 Aug 14, 2024	BUY	$3.0 - $4.88 $42,900 - $69,784	14,300 Added 152.13%	23,700 $106,000
Q1 2024 May 15, 2024	BUY	$3.25 - $5.0 $25,675 - $39,500	7,900 Added 526.67%	9,400 $31,000
Q4 2023 Feb 14, 2024	BUY	$2.01 - $3.51 $2,411 - $4,212	1,200 Added 400.0%	1,500 $5,000
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.45 $906 - $1,335	300 New	300 $0
Q1 2023 May 15, 2023	BUY	$2.19 - $3.27 $2,628 - $3,924	1,200 New	1,200 $2,000

4.91M

700

31.3K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $96.4M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.